|
Volumn 91, Issue 2, 2002, Pages 324-326
|
Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome
|
Author keywords
Erythropoietin; Hemolytic uremic syndrome; Mitomycin
|
Indexed keywords
ERYTHROPOIETIN;
FLUOROURACIL;
HAPTOGLOBIN;
MITOMYCIN;
ANTINEOPLASTIC ANTIBIOTIC;
ADULT;
ANEMIA;
ARTICLE;
BLOOD TRANSFUSION;
CANCER RECURRENCE;
CASE REPORT;
CLINICAL FEATURE;
COLON ADENOCARCINOMA;
CONTROLLED STUDY;
DISEASE COURSE;
DOSE RESPONSE;
DRUG EFFECT;
ENDOTHELIUM;
FEMALE;
HEMODIALYSIS;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
KIDNEY FAILURE;
KIDNEY FUNCTION;
PRIORITY JOURNAL;
THROMBOCYTE;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
CHEMICALLY INDUCED DISORDER;
COLON TUMOR;
MIDDLE AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
CASE REPORT;
COLONIC NEOPLASMS;
ERYTHROPOIETIN;
FEMALE;
HEMOLYTIC-UREMIC SYNDROME;
HUMAN;
MIDDLE AGE;
MITOMYCIN;
HUMANS;
MIDDLE AGED;
|
EID: 0036016905
PISSN: 00282766
EISSN: None
Source Type: Journal
DOI: 10.1159/000058411 Document Type: Article |
Times cited : (6)
|
References (14)
|